Saturday - July 25, 2026

Category Archives: Science

STEMart Enhances Medical Device Safety Testing with New In Vitro Micronucleus Test Service

STEMart introduces In Vitro Micronucleus Test service to meet the genotoxicity testing requirements for medical devices. STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the availability of its robust In Vitro Micronucleus … Continue reading →

Music Beats Cancer & The Residence Yacht Club Announce Holiday Celebration to Unite Innovators, Supporters, and Advocates in the Fight Against Cancer

Attendees can RSVP by scanning the QR code on the event flyer. The event will bring people together and highlight the urgent need to champion early-stage cancer breakthroughs. Miami Beach, Fla. – December 15, 2025 – Music Beats Cancer, a nonprofit … Continue reading →

CD Bioparticles Launches Additive Powders to Drive Innovation in 3D Printing and Advanced Manufacturing

CD Bioparticles announces a comprehensive range of Additive Powders for various applications. With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced the expansion of its product portfolio with a comprehensive range of Additive Powders, … Continue reading →

Alcohol Use Disorder Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Alcohol Use Disorder Pipeline Insight 2025” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Alcohol Use Disorder pipeline landscape. It covers the Alcohol Use Disorder pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Duchenne Muscular Dystrophy Clinical Trial Pipeline Shows Potential with Active Contributions from 75+ Key Companies | DelveInsight

DelveInsight’s “Duchenne Muscular Dystrophy Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Duchenne Muscular Dystrophy pipeline landscape. It covers the Duchenne Muscular Dystrophy pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Schizophrenia Clinical Trial Pipeline Accelerates as 55+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Schizophrenia Pipeline Insight 2025” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in the Schizophrenia pipeline landscape. It covers the Schizophrenia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Schizophrenia Pipeline … Continue reading →

Peanut Allergy Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Peanut Allergy Pipeline Insight, 2025” report provides comprehensive insights about 12+ companies and 15+ pipeline drugs in Peanut Allergy pipeline landscape. It covers the Peanut Allergy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Breast Cancer Clinical Trial Pipeline Gains Momentum: 250+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Breast Cancer Pipeline Insight 2025” report provides comprehensive insights about 250+ Breast Cancer companies and 300+ pipeline drugs in the Breast Cancer pipeline landscape. It covers the Breast Cancer pipeline drugs profiles, including clinical and nonclinical stage products. It … Continue reading →